Rockwell Medical (RMTI) Other financing activities (2012 - 2019)

Rockwell Medical's (RMTI) quarterly Other financing activities came in at $100.0 in Q3 2019, down 99.93% on a QoQ basis from $147900.0 in Q1 2019.

Rockwell Medical (RMTI) Other financing activities (2012 - 2019) Analysis & Trends

Rockwell Medical (RMTI) has 2 years of Other financing activities data on file, last reported at $100.0 in Q3 2019.

Quarterly Other financing activities changed N/A year-over-year to $100.0 in Q3 2019, while the trailing twelve-month figure through Jun 2020 was $100.0 (changed N/A YoY) and the FY2021 annual result came in at $107000.0, changed N/A from the prior year.
Other financing activities retreated to $100.0 in Q3 2019, from $147900.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $147900.0 in Q1 2019 to a low of $100.0 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-
2	Teva Pharmaceutical Industries	43.08 Bn	39.43 Bn	2.15 Bn
3	Zoetis	31.54 Bn	29.87 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn
5	United Therapeutics	22.12 Bn	19.46 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-
10	Rockwell Medical	30.01 Mn	5.21 Mn	3.24 Mn

Download Data